The Chosun Ilbo on MSN
MSD Korea maintains R&D leadership with Keytruda
MSD is a company that is ‘serious about science.’ In 2024, its global research and development investment reached $17.9 ...
The U.S. Food and Drug Administration’s (or FDA) approval for Keytruda on October 2, 2015, to treat patients suffering with advanced non-small cell lung cancer (or NSCLC) is considered to be a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback